Class information for:
Level 1: ERYTHROPOIETIN//DARBEPOETIN ALFA//RENAL ANEMIA

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1304 2627 32.7 72%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
875 10801 ERYTHROPOIETIN//DARBEPOETIN ALFA//ANEMIA

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ERYTHROPOIETIN Author keyword 81 12% 24% 634
2 DARBEPOETIN ALFA Author keyword 59 43% 4% 105
3 RENAL ANEMIA Author keyword 56 48% 3% 86
4 EPOETIN Author keyword 55 43% 4% 96
5 ERYTHROPOIESIS STIMULATING AGENTS Author keyword 39 37% 3% 84
6 RECOMBINANT HUMAN ERYTHROPOIETIN Author keyword 38 28% 4% 114
7 RENAL ANAEMIA Author keyword 31 67% 1% 28
8 CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR Author keyword 29 75% 1% 21
9 CERA Author keyword 28 64% 1% 28
10 ERYTHROPOIESIS STIMULATING AGENT Author keyword 27 47% 2% 42

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ERYTHROPOIETIN 81 12% 24% 634 Search ERYTHROPOIETIN Search ERYTHROPOIETIN
2 DARBEPOETIN ALFA 59 43% 4% 105 Search DARBEPOETIN+ALFA Search DARBEPOETIN+ALFA
3 RENAL ANEMIA 56 48% 3% 86 Search RENAL+ANEMIA Search RENAL+ANEMIA
4 EPOETIN 55 43% 4% 96 Search EPOETIN Search EPOETIN
5 ERYTHROPOIESIS STIMULATING AGENTS 39 37% 3% 84 Search ERYTHROPOIESIS+STIMULATING+AGENTS Search ERYTHROPOIESIS+STIMULATING+AGENTS
6 RECOMBINANT HUMAN ERYTHROPOIETIN 38 28% 4% 114 Search RECOMBINANT+HUMAN+ERYTHROPOIETIN Search RECOMBINANT+HUMAN+ERYTHROPOIETIN
7 RENAL ANAEMIA 31 67% 1% 28 Search RENAL+ANAEMIA Search RENAL+ANAEMIA
8 CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR 29 75% 1% 21 Search CONTINUOUS+ERYTHROPOIETIN+RECEPTOR+ACTIVATOR Search CONTINUOUS+ERYTHROPOIETIN+RECEPTOR+ACTIVATOR
9 CERA 28 64% 1% 28 Search CERA Search CERA
10 ERYTHROPOIESIS STIMULATING AGENT 27 47% 2% 42 Search ERYTHROPOIESIS+STIMULATING+AGENT Search ERYTHROPOIESIS+STIMULATING+AGENT

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 RECOMBINANT HUMAN ERYTHROPOIETIN 214 19% 38% 992
2 ANEMIA MANAGEMENT 135 68% 4% 118
3 GLYCOL EPOETIN BETA 85 89% 1% 39
4 PREDIALYSIS PATIENTS 70 41% 5% 133
5 EPOETIN ALPHA 67 23% 10% 253
6 RHUEPO 67 61% 3% 70
7 EPOETIN 56 35% 5% 130
8 HEMOGLOBIN LEVEL VARIABILITY 51 91% 1% 21
9 HEMATOCRIT VALUES 51 60% 2% 56
10 MAINTAINS HEMOGLOBIN CONCENTRATIONS 48 100% 1% 17

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease 2010 88 42 83%
Anaemia management and mortality risk in chronic kidney disease 2013 19 81 75%
Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to Reduce Cardiovascular Events with Aranesp (R) Therapy (TREAT) Study 2010 45 13 85%
New Anemia Therapies: Translating Novel Strategies From Bench to Bedside 2012 26 35 51%
Arterial Hypertension Induced by Erythropoietin and Erythropoiesis-Stimulating Agents (ESA) 2009 58 71 89%
Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure 2004 292 276 46%
What is causing the mortality in treating the anemia of chronic kidney disease: erythropoietin dose or hemoglobin level? 2010 31 31 71%
Critical appraisal of randomized controlled trials of anemia correction in patients with renal failure 2011 11 15 87%
Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients 2014 1 80 93%
Erythropoietin and Resistant Hypertension in CKD 2014 1 39 90%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 NEPHROL DIALYSIS RENAL TRANSPLANT 9 38% 0.7% 19
2 CHRON DIS GRP 5 15% 1.1% 28
3 BENEFICIARY CHOICES 3 42% 0.2% 5
4 NEPHROL ANALYT SERV 2 27% 0.3% 8
5 HEALTHCARE BUSINESS ADV MODELING 2 67% 0.1% 2
6 SMDP INCURABILI HOSP 2 67% 0.1% 2
7 HYPERTENS PREVENT NEPHROL 2 50% 0.1% 3
8 HLTH CARE FINANCING ADM 2 43% 0.1% 3
9 ANAEMIA COORDINATOR PROGRAMME 1 100% 0.1% 2
10 DIAVERUM GRP 1 100% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000246516 IRON SUCROSE//INTRAVENOUS IRON//IRON DEXTRAN
2 0.0000220008 POSTTRANSPLANT ERYTHROCYTOSIS//POST TRANSPLANT ERYTHROCYTOSIS//ERYTHROCYTOSIS
3 0.0000163749 CARDIORENAL ANEMIA SYNDROME//CONGEST HEART FAILURE UNIT//PL CARDIOVASC SYST
4 0.0000137042 ANTIANEMIC AGENTS//CAS 11096 26 7//RECOMBINANT HUMAN ERYTHROPOIETIN RHEPO
5 0.0000093520 CHEMOTHERAPY INDUCED ANEMIA//EPOETIN ALFA//CHEMOTHERAPY INDUCED ANAEMIA
6 0.0000090149 UREMIC CARDIOMYOPATHY//EXCELLENCE EUROPEAN SOC HYPERTENS//NEFROL DIALISI TR IANTO
7 0.0000083267 ERYTHROPOIETIN//CELLULAR MOL CEREBRAL I EMIA//CARBAMYLATED ERYTHROPOIETIN
8 0.0000072039 BIOSIMILARS//BIOSIMILAR//ANTI ERYTHROPOIETIN ANTIBODIES
9 0.0000069390 PHOSPHATE DEPLETION//CA DYNAMICS//CADAVERIC RENAL ALLOGRAFT
10 0.0000061155 ANEMIA IN THE ELDERLY//ANEMIA IN ELDERLY//ANEMIA OF CHRONIC INFLAMMATION